About William Yelle
Form D filings for Violet Therapeutics in 2023 list William Yelle as executive officer and director.
William Yelle first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name William Yelle in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people William Yelle works with at each company, as listed on that company's latest Form D.
Violet Therapeutics, Inc. · Form D, May 5, 2023